{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:06:17Z","timestamp":1790136377463,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004492","name":"National Youth Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.clim.2020.108592","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T21:41:17Z","timestamp":1599774077000},"page":"108592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Clinical markers combined with HMGB1 polymorphisms to predict efficacy of conventional DMARDs in rheumatoid arthritis patients"],"prefix":"10.1016","volume":"221","author":[{"given":"Ke","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bomiao","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirixiati","family":"Aihaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2020.108592_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.0105-2896.2009.00869.x","article-title":"Inflammatory arthritis--an exciting confluence of human and animal research","volume":"233","author":"Laufer","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2020.108592_bb0010","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/1756-185X.12362","article-title":"Multidrug resistance protein-1 expression, function and polymorphisms in patients with rheumatoid arthritis not responding to methotrexate","volume":"17","author":"Prasad","year":"2014","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.clim.2020.108592_bb0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2020.108592_bb0020","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1007\/s10067-019-04761-5","article-title":"Management of rheumatoid arthritis: 2019 updated consensus recommendations from the Hong Kong Society of Rheumatology","volume":"38","author":"Ho","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2020.108592_bb0025","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/acr.20453","article-title":"Reduction of long-term disability in inflammatory polyarthritis by early and persistent suppression of joint inflammation: results from the Norfolk arthritis register","volume":"63","author":"Scire","year":"2011","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.clim.2020.108592_bb0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/ard.2008.088237","article-title":"Can clinical factors at presentation be used to predict outcome of treatment with methotrexate in patients with early inflammatory polyarthritis?","volume":"68","author":"Hider","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2020.108592_bb0035","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/rheumatology\/kel149","article-title":"Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology biologics register","volume":"45","author":"Hyrich","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2020.108592_bb0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/rheumatology\/key263","article-title":"Autoantibody status is not associated with early treatment response to first-line methotrexate in patients with early rheumatoid arthritis","volume":"58","author":"Dekkers","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2020.108592_bb0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13075-019-1815-0","article-title":"In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response","volume":"21","author":"de Moel","year":"2019","journal-title":"Arthrit. Res. Ther."},{"key":"10.1016\/j.clim.2020.108592_bb0050","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00296-009-0978-4","article-title":"Third generation anti-cyclic citrullinated peptide antibodies do not predict anti-TNF-alpha treatment response in rheumatoid arthritis","volume":"30","author":"Dejaco","year":"2010","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.clim.2020.108592_bb0055","first-page":"701","article-title":"Association of anti-CCP positivity and carriage of TNFRII susceptibility variant with anti-TNF-alpha response in rheumatoid arthritis","volume":"29","author":"Vasilopoulos","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2020.108592_bb0060","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13075-017-1401-2","volume":"19","author":"Takeuchi","year":"2017","journal-title":"Arthrit. Res. Ther."},{"key":"10.1016\/j.clim.2020.108592_bb0065","first-page":"159","article-title":"Predictive genetic biomarkers for the efficacy of methotrexate in rheumatoid arthritis: a systematic review","volume":"20","author":"Eektimmerman","year":"2020","journal-title":"Pharm. J."},{"key":"10.1016\/j.clim.2020.108592_bb0070","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/rheumatology\/ket134","article-title":"The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis","volume":"52","author":"Chen","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2020.108592_bb0075","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s13075-015-0892-y","article-title":"Autophagy induction contributes to the resistance to methotrexate treatment in rheumatoid arthritis fibroblast-like synovial cells through high mobility group box chromosomal protein 1","volume":"17","author":"Xu","year":"2015","journal-title":"Arthrit. Res. Ther."},{"key":"10.1016\/j.clim.2020.108592_bb0080","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.7150\/ijms.21773","article-title":"Prognostic significance of high-mobility group box protein 1 genetic polymorphisms in rheumatoid arthritis disease outcome","volume":"14","author":"Wang","year":"2017","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.clim.2020.108592_bb0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2020.108592_bb0090","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/annrheumdis-2015-208324","article-title":"Optimisation of a treat-to-target approach in rheumatoid arthritis: strategies for the 3-month time point","volume":"75","author":"Aletaha","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2020.108592_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7603\/s40681-014-0009-y","article-title":"Genetic susceptibility to idiopathic membranous nephropathy in high-prevalence area, Taiwan","volume":"4","author":"Chen","year":"2014","journal-title":"Biomed. (Taipei)"},{"key":"10.1016\/j.clim.2020.108592_bb0100","doi-asserted-by":"crossref","first-page":"295081","DOI":"10.1155\/2012\/295081","article-title":"Enhanced HMGB1 expression may contribute to Th17 cells activation in rheumatoid arthritis","volume":"2012","author":"Shi","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.clim.2020.108592_bb0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11010-016-2783-1","article-title":"Methotrexate affects HMGB1 expression in rheumatoid arthritis, and the downregulation of HMGB1 prevents rheumatoid arthritis progression","volume":"420","author":"Li","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.clim.2020.108592_bb0110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.wneu.2017.01.121","article-title":"Impact of high-mobility group box 1 polymorphism on delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage","volume":"101","author":"Hendrix","year":"2017","journal-title":"World Neurosurg."},{"key":"10.1016\/j.clim.2020.108592_bb0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbmt.2009.10.002","article-title":"Association of HMGB1 polymorphisms with outcome after allogeneic hematopoietic cell transplantation","volume":"16","author":"Kornblit","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.clim.2020.108592_bb0120","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10815-015-0493-3","article-title":"High mobility group box 1 protein polymorphism affects susceptibility to recurrent pregnancy loss by up-regulating gene expression in chorionic villi","volume":"32","author":"Jin","year":"2015","journal-title":"J. Assist. Reprod. Genet."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162030752X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162030752X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:01:35Z","timestamp":1761494495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166162030752X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":24,"alternative-id":["S152166162030752X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2020.108592","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical markers combined with HMGB1 polymorphisms to predict efficacy of conventional DMARDs in rheumatoid arthritis patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2020.108592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108592"}}